APA (7th ed.) Citation

Zhang S, Wu P, Liu J, Du Y, & Yang Z. (2021). Roflumilast Attenuates Doxorubicin-Induced Cardiotoxicity by Targeting Inflammation and Cellular Senescence in Cardiomyocytes Mediated by SIRT1. Dove Medical Press.

Chicago Style (17th ed.) Citation

Zhang S, Wu P, Liu J, Du Y, and Yang Z. Roflumilast Attenuates Doxorubicin-Induced Cardiotoxicity by Targeting Inflammation and Cellular Senescence in Cardiomyocytes Mediated by SIRT1. Dove Medical Press, 2021.

MLA (9th ed.) Citation

Zhang S, et al. Roflumilast Attenuates Doxorubicin-Induced Cardiotoxicity by Targeting Inflammation and Cellular Senescence in Cardiomyocytes Mediated by SIRT1. Dove Medical Press, 2021.